Dow Up 0.76% Nasdaq Up 0.69%

Nektar Therapeutics (NKTR)

-NasdaqGS
13.15 Down 0.10(0.75%) Oct 24, 4:00PM EDT
Prev Close:13.25
Open:13.27
Bid:N/A
Ask:13.89 x 600
1y Target Est:17.75
Beta:1.44
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:12.93 - 13.58
52wk Range:8.87 - 15.34
Volume:854,920
Avg Vol (3m):1,292,180
Market Cap:1.67B
P/E (ttm):N/A
EPS (ttm):-1.19
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NKTR

Comparison

Symbol% ChgMkt Cap
NKTRDown 0.75%1.67B
BMYUp 2.15%88.91B
ENZNDown 0.98%44.57M
GSKUp 0.95%109.99B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):12.02
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.65
Quarterly EPS Est (Sep-14) :0.39
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-0.58

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Nektar Therapeutics, a clinical-stage biopharmaceutical company, develops drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback